[Epidemiology of blindness, especially in diabetes--overview of current studies]
1Abteilung Biometrie und Epidemiologie, Heinrich-Heine-Universität Düsseldorf.
Abstract:
The main targets of the St. Vincent declaration of 1989 and of the WHO programme Health for All 2000 are reduction of loss of sight and especially of blindness associated with diabetes. However, hardly any data on blindness are available that describe a basic situation and would be suitable as a starting point for planning interventions and assessing them from the viewpoints of efficacy and efficiency. Only few studies have been conducted so far with detailed population-related data on the incidence and relative risks of blindness, as well as the associated mortality. The article reviews these studies and presents investigations that are presently being conducted in our department in this regard. The results obtained so far point to an increased incidence of blindness in peoples with diabetes, high relative and attributable risks especially in the young and middle-aged, and increased mortality rates subsequent to blindness, compared to the total population.
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Retinopathy
Diabetic Nephropathy


